AAAAAA
Results: 1-25/36
Authors:
Leung, TW
Cheung, ANY
Cheng, DKL
Wong, LC
Ngan, HYS
Citation: Tw. Leung et al., Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: Correlation with clinical prognosis, ONCOL REP, 8(5), 2001, pp. 1159-1164
Authors:
Ngan, HYS
Cheung, ANY
Liu, SS
Cheng, DKL
Ng, TY
Wong, LC
Citation: Hys. Ngan et al., Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis, ONCOL REP, 8(3), 2001, pp. 557-561
Authors:
Ngan, HYS
Cheung, ANY
Liu, SS
Cheng, DKL
Ng, TY
Wong, LC
Citation: Hys. Ngan et al., Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: Correlation with human papillomavirus and prognosis, TUMOR BIOL, 22(3), 2001, pp. 176-183
Authors:
Liu, SS
Tsang, BK
Cheung, ANY
Xue, WC
Cheng, DKL
Ng, TY
Wong, LC
Ngan, HYS
Citation: Ss. Liu et al., Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma, EUR J CANC, 37(9), 2001, pp. 1104-1110
Authors:
Ip, SM
Huang, TG
Yeung, WSB
Ngan, HYS
Citation: Sm. Ip et al., pRb-expressing adenovirus Ad5-Rb attenuates the p53-induced apoptosis in cervical cancer cell lines, EUR J CANC, 37(18), 2001, pp. 2475-2483
Authors:
Huang, TG
Ip, SM
Yeung, WSB
Ngan, HYS
Citation: Tg. Huang et al., Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells, CANCER INV, 19(4), 2001, pp. 360-368
Authors:
Liu, VWS
Tsang, P
Yip, A
Ng, TY
Wong, LC
Ngan, HYS
Citation: Vws. Liu et al., Low incidence of HPV DNA in sera of pretreatment cervical cancer patients, GYNECOL ONC, 82(2), 2001, pp. 269-272
Authors:
Chan, YM
Ngan, HYS
Yip, PSF
Li, BYG
Lau, OWK
Tang, GWK
Citation: Ym. Chan et al., Psychosocial adjustment in gynecologic cancer survivors: A longitudinal study on risk factors for maladjustment, GYNECOL ONC, 80(3), 2001, pp. 387-394
Authors:
Liu, VWS
Shi, HH
Cheung, ANY
Chiu, PM
Leung, TW
Nagley, P
Wong, LC
Ngan, HYS
Citation: Vws. Liu et al., High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas, CANCER RES, 61(16), 2001, pp. 5998-6001
Authors:
Shen, DH
Khoo, US
Xue, WC
Ngan, HYS
Wang, JL
Liu, VWS
Chan, YK
Cheung, ANY
Citation: Dh. Shen et al., Primary peritoneal malignant mixed Mullerian tumors - A clinicopathologic,immunohistochemical, and genetic study, CANCER, 91(5), 2001, pp. 1052-1060
Authors:
Chen, CL
Ip, SM
Cheng, D
Wong, LC
Ngan, HYS
Citation: Cl. Chen et al., Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer, CLIN CANC R, 6(2), 2000, pp. 474-479
Authors:
Chen, CL
Ip, SM
Cheng, D
Wong, LC
Ngan, HYS
Citation: Cl. Chen et al., p73 gene expression in ovarian cancer tissues and cell lines, CLIN CANC R, 6(10), 2000, pp. 3910-3915
Authors:
Ngan, HYS
Liu, VWS
Liu, SS
Cheng, DKL
Ng, TY
Wong, LC
Citation: Hys. Ngan et al., Homozygous arginine at codon 72 of p53 has no prognostic significance in cervical cancer, TUMOR BIOL, 21(3), 2000, pp. 135-138
Authors:
Huang, TG
Ip, SM
Yeung, WSB
Ngan, HYS
Citation: Tg. Huang et al., Changes in p21(WAF1), pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus, EUR J CANC, 36(2), 2000, pp. 249-256
Authors:
Chan, YM
Cheng, DKL
Cheung, ANY
Ngan, HYS
Wong, LC
Citation: Ym. Chan et al., Female urethral adenocarcinoma arising from urethritis glandularis, GYNECOL ONC, 79(3), 2000, pp. 511-514
Authors:
Ng, TY
Ngan, HYS
Cheng, DKL
Wong, LC
Citation: Ty. Ng et al., Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples, GYNECOL ONC, 76(3), 2000, pp. 405-408
Authors:
Benedet, JL
Bender, H
Jones, H
Ngan, HYS
Pecorelli, S
Citation: Jl. Benedet et al., FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers, INT J GYN O, 70(2), 2000, pp. 209-262
Authors:
Liu, VWS
Nagley, P
Ngan, HYS
Citation: Vws. Liu et al., One-step directional cloning of blunt-ended polymerase chain reaction products, ANALYT BIOC, 287(2), 2000, pp. 349-352
Authors:
Wong, LC
Ngan, HYS
Cheng, DKL
Ng, TY
Citation: Lc. Wong et al., Methotrexate infusion in low-risk gestational trophoblastic disease, AM J OBST G, 183(6), 2000, pp. 1579-1582
Authors:
Cheung, ANY
Shen, DH
Khoo, US
Chiu, MPM
Tin, VPC
Chung, LP
Ngan, HYS
Citation: Any. Cheung et al., Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease: correlation with mdm2, proliferation index, and clinicopathologic parameters, INT J GYN C, 9(2), 1999, pp. 123-130
Authors:
Ngan, HYS
Cheung, ANY
Liu, SS
Yip, PSF
Tsao, SW
Citation: Hys. Ngan et al., Abnormal expression or mutation of TP53 and HPV in vulvar cancer, EUR J CANC, 35(3), 1999, pp. 481-484
Authors:
Ngan, HYS
Liu, SS
Yu, H
Liu, KL
Cheung, ANY
Citation: Hys. Ngan et al., Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia, EUR J CANC, 35(10), 1999, pp. 1546-1550
Authors:
Zhang, DK
Ngan, HYS
Cheng, RYS
Cheung, ANY
Liu, SS
Tsao, SW
Citation: Dk. Zhang et al., Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer, EUR J CANC, 35(1), 1999, pp. 154-160
Authors:
Khoo, US
Ozcelik, H
Cheung, ANY
Chow, LWC
Ngan, HYS
Done, SJ
Liang, ACT
Chan, VWY
Au, GKH
Ng, WF
Poon, CSP
Leung, YF
Loong, F
Ip, P
Chan, GSW
Andrulis, IL
Lu, J
Ho, FCS
Citation: Us. Khoo et al., Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovariancancer, ONCOGENE, 18(32), 1999, pp. 4643-4646
Authors:
Wong, SYY
Ngan, HYS
Chan, CCW
Cheung, ANY
Citation: Syy. Wong et al., Apoptosis in gestational trophoblastic disease is correlated with clinicaloutcome and Bcl-2 expression but not Bax expression, MOD PATHOL, 12(11), 1999, pp. 1025-1033